Lori Krim Gough has over 25 years in drug discovery and business development. She is a Partner at Epidarex Capital and serves on multiple boards.
What Lori can write
Career
- GSK
- Tmunity Therapeutics · VP of Corporate Development
- NeuExcell Therapeutics · Chief Business & Strategy Officer
- Pfizer
- GSK
- Tmunity Therapeutics · Vice President of Corporate Development
- NeuExcell Therapeutics Inc. · Chief Business and Strategy Officer
- Epidarex Capital · PartnerNow
Investments named in public bios
Focus
Education
Also at Epidarex Capital
Partners like Lori
At firms with a similar stage, sector and check size.
Alert me when Epidarex Capital is active
One email when Lori's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Lori Krim Gough?
Lori Krim Gough has over 25 years in drug discovery and business development. She is a Partner at Epidarex Capital and serves on multiple boards.
How much does Lori Krim Gough invest?
Epidarex Capital has not reported a check size. It invests at seed, series a.
How do I pitch Lori Krim Gough?
Email [email protected], the firm's inbox for founders, and name Lori in the subject. A warm intro from a founder Epidarex Capital backed works better.
What did Lori Krim Gough do before Epidarex Capital?
GSK; VP of Corporate Development at Tmunity Therapeutics; Chief Business & Strategy Officer at NeuExcell Therapeutics; Pfizer; GSK; Vice President of Corporate Development at Tmunity Therapeutics; Chief Business and Strategy Officer at NeuExcell Therapeutics Inc..
Last updated 2026-10-15. Is this you? Ask for a correction.